Cargando…
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144544/ https://www.ncbi.nlm.nih.gov/pubmed/32273593 http://dx.doi.org/10.1038/s41581-020-0284-7 |
_version_ | 1783519854835269632 |
---|---|
author | Ronco, Claudio Reis, Thiago |
author_facet | Ronco, Claudio Reis, Thiago |
author_sort | Ronco, Claudio |
collection | PubMed |
description | The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19. |
format | Online Article Text |
id | pubmed-7144544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-71445442020-04-09 Kidney involvement in COVID-19 and rationale for extracorporeal therapies Ronco, Claudio Reis, Thiago Nat Rev Nephrol Comment The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19. Nature Publishing Group UK 2020-04-09 2020 /pmc/articles/PMC7144544/ /pubmed/32273593 http://dx.doi.org/10.1038/s41581-020-0284-7 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Ronco, Claudio Reis, Thiago Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title | Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title_full | Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title_fullStr | Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title_full_unstemmed | Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title_short | Kidney involvement in COVID-19 and rationale for extracorporeal therapies |
title_sort | kidney involvement in covid-19 and rationale for extracorporeal therapies |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144544/ https://www.ncbi.nlm.nih.gov/pubmed/32273593 http://dx.doi.org/10.1038/s41581-020-0284-7 |
work_keys_str_mv | AT roncoclaudio kidneyinvolvementincovid19andrationaleforextracorporealtherapies AT reisthiago kidneyinvolvementincovid19andrationaleforextracorporealtherapies |